Comment on "Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis"
-
Published:2024-01-03
Issue:
Volume:
Page:83-84
-
ISSN:2146-3123
-
Container-title:Balkan Medical Journal
-
language:
-
Short-container-title:Balkan Med J
Publisher
Galenos Yayinevi
Reference13 articles.
1. 1. Birdal O, Saygı M, Doğan R, Tezen O, Karagöz A, Tanboğa İH. Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis. Balkan Med J. 2023;40:324-332. [CrossRef]
2. 2. Glynn RJ, Danielson E, Fonseca FA, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009;360:1851-1861. [CrossRef]
3. 3. Zhang X, Xing L, Jia X, et al. Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials. Cardiovasc Ther. 2020;3987065. [CrossRef]
4. 4. Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005;25:287-294. [CrossRef]
5. 5. Kaba NK, Francis CW, Moss AJ, et al. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. J Thromb Haemost. 2004;2:718-725. [CrossRef]